Soft regulations in pharmaceutical policy making: An overview of current approaches and their Consequences. Wettermark, B., Godman, B., Jacobsson, B., & Haaijer-Ruskamp, F. M. Applied Health Economics and Health Policy, 7(3):137–147, September, 2009.
Soft regulations in pharmaceutical policy making: An overview of current approaches and their Consequences [link]Paper  doi  bibtex   
@article{wettermark_soft_2009-1,
	title = {Soft regulations in pharmaceutical policy making: {An} overview of current approaches and their {Consequences}},
	volume = {7},
	issn = {1175-5652, 1179-1896},
	shorttitle = {Soft regulations in pharmaceutical policy making},
	url = {http://link.springer.com/10.1007/BF03256147},
	doi = {10.1007/BF03256147},
	language = {en},
	number = {3},
	urldate = {2019-05-01},
	journal = {Applied Health Economics and Health Policy},
	author = {Wettermark, Björn and Godman, Brian and Jacobsson, Bengt and Haaijer-Ruskamp, Flora M.},
	month = sep,
	year = {2009},
	pages = {137--147},
	file = {Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:/Users/neil.hawkins/Zotero/storage/GDVW3UZA/Wettermark et al. - 2009 - Soft regulations in pharmaceutical policy making .pdf:application/pdf},
}

Downloads: 0